BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16550020)

  • 21. Posttransplant lymphoproliferative disorder of the lung in a renal transplant recipient treated successfully with surgery.
    Foroncewicz B; Mucha K; Usiekniewicz J; Chmura A; Kryst P; Sołdacki D; Paczek L
    Transplant Proc; 2006; 38(1):173-6. PubMed ID: 16504695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete resolution of posttransplant lymphoproliferative disorder (diffuse large B-cell lymphoma) with reduction of immunosuppressive therapy.
    Ryu HJ; Hahn JS; Kim YS; Park K; Yang WI; Lee JD
    Yonsei Med J; 2004 Jun; 45(3):527-32. PubMed ID: 15227742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
    Azarpira N; Torabineghad S; Rakei M
    Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoproliferative disorders: CT findings in immunocompromised children.
    Donnelly LF; Frush DP; Marshall KW; White KS
    AJR Am J Roentgenol; 1998 Sep; 171(3):725-31. PubMed ID: 9725305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant Epstein-Barr virus (EBV)-positive B-cell and EBV-negative T-cell posttransplant lymphoproliferative disorders after renal allografting: pathogenetic implications.
    Au WY; Lam MF; Pang A; Leung RY; Kwong YL
    Transplantation; 2011 Dec; 92(12):e67-8. PubMed ID: 22158471
    [No Abstract]   [Full Text] [Related]  

  • 27. [Renal-duodenal fistula in the context of a renal tumor].
    Ruíz Plazas X; Vicenç Vicenç A; García Montes F; Morón Canís JM; Ozonas Moragues M
    Arch Esp Urol; 2008; 61(1):83. PubMed ID: 18405036
    [No Abstract]   [Full Text] [Related]  

  • 28. Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients.
    Smith JM; Corey L; Healey PJ; Davis CL; McDonald RA
    Transplantation; 2007 Jun; 83(11):1423-8. PubMed ID: 17565314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posttransplant lymphoproliferative disease in a pediatric patient as seen on PET/CT scan.
    Bagga S
    Clin Nucl Med; 2007 Jul; 32(7):553-4. PubMed ID: 17581345
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantification of Epstein-Barr viral load and determination of a cut-off value to predict the risk of post-transplant lymphoproliferative disease in a renal transplant cohort.
    Baiocchi OC; Colleoni GW; Caballero OL; Vettore AL; Andrade AL; Pestana JO
    Haematologica; 2004 Mar; 89(3):366-8. PubMed ID: 15020282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using helical CT to evaluate renal cell carcinoma in patients undergoing hemodialysis: value of early enhanced images.
    Takebayashi S; Hidai H; Chiba T; Takagi H; Koike S; Matsubara S
    AJR Am J Roentgenol; 1999 Feb; 172(2):429-33. PubMed ID: 9930797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dermatopathology of skin cancer in solid organ transplant recipients.
    Stoff B; Salisbury C; Parker D; O'Reilly Zwald F
    Transplant Rev (Orlando); 2010 Oct; 24(4):172-89. PubMed ID: 20709518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
    Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT of renal cell carcinoma in patients on chronic hemodialysis.
    Siegel SC; Sandler MA; Alpern MB; Pearlberg JL
    AJR Am J Roentgenol; 1988 Mar; 150(3):583-5. PubMed ID: 3257614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic native renal carcinoma in renal transplant recipients.
    O'Donnell C; Cutner A; Williams G
    Nephrol Dial Transplant; 1988; 3(5):690-3. PubMed ID: 3146731
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal cell carcinoma containing fat: demonstration with CT.
    Hélénon O; Chrétien Y; Paraf F; Melki P; Denys A; Moreau JF
    Radiology; 1993 Aug; 188(2):429-30. PubMed ID: 8327691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of renal cell carcinoma in horseshoe kidney].
    Otero-García JM; Maldonado-Alcaraz E; López-Sámano VA
    Gac Med Mex; 2005; 141(4):305-7. PubMed ID: 16164126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant lymphoma accompanied by renal cell carcinoma - a not so rare coincidence?
    Wedemeyer J; Gebel MJ; Lotz J; Schlue J; Manns MP; Bleck JS
    Ultraschall Med; 2004 Feb; 25(1):65-9. PubMed ID: 14961427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients.
    Doublet JD; Peraldi MN; Gattegno B; Thibault P; Sraer JD
    J Urol; 1997 Jul; 158(1):42-4. PubMed ID: 9186319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET for Detection of Primary Tracheobronchial T-/Natural Killer-Cell-Derived Posttransplant Lymphoproliferative Disorder After Lung Transplantation.
    Derlin T; Braubach P; Kreipe HH; Hueper K
    Clin Nucl Med; 2017 Dec; 42(12):988-989. PubMed ID: 29076909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.